维普期刊资源整合服务平台（V6.5）

160篇 您的检索式：作者名="OA O"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ-Ⅰ-Ⅱ study of two different doses and schedules of pralatrexate,a high-affinity substrate for the reduced folate carrier,in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies显示文摘	O'Connor OA Horwitz S Hamlin P	2009	J Clin Oncol2009，27，26：	1
2	Eukaryotic translation initia-tion factor 4E induced progression of primary human mammary epi-thelial cells along the cancer pathway is associated with targetedtranslational deregulation of oncogenic drivers and inhibitors显示文摘	Larsson O Li S Issaenko OA	2007	Cancer Res2007，67，14：	1
3	Clinical and audiometric features of presbycusis in Nigerians 显示文摘	Sogebi OA Olusoga-Peters OO Oluwapelumi O	2013	Afr Health Sci2013，13，4：	1
4	Prevention of adhesions with crystalloids during laparoscopic surgery in mice 显示文摘	Elkelani OA Molinas CR Mynbaev O	2002	J Am Assoc Gynecol Laparosc2002，9，4：	1
5	Diffuse aggressive lymphoma显示文摘	Fisher R I Miller TP O'Connor OA	2004	Hematology2004，1，：	1
6	Navitoclax,a targeted high-affinity inhibitor of BCL-2,in lymphoid malignancies:A phase Ⅰ dose-escalation study of safety,pharmacokinetics,pharmacodynamics,and antitumour activity显示文摘	Wilson WH O'Connor OA Czuczman MS		0，，12：	1
7	Marked clinical activity of the proteasome inhibitor bortezomib in patients with follicular and mantle-cell lymphoma显示文摘	O Connor OA	2005	Clin Lymphoma Myeloma2005，6，3：	1
8	Vulnerability of pathogenic binfihns to Micavibrio aeniginosavorus 显示文摘	Kadouri D Venzon NC O' Toole OA	2007	Appl Environ Microbiol2007，2，：	1
9	Dose-response and time-course of effect of rocuronium bromide in paediatric patients显示文摘	Meretoja OA Taivainen T Erkola O	1995	Eur J Anaesth1995，12，11：	1
10	The risk of transfu- sion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria显示文摘	Erhahor O Ejele OA Nwauehe CA	2006	NigerJ ClinPraet2006，9，1：	1
11	A multicentre phase Ⅱ clinical experience with the novel aza-epothilone Ixabepilone(BMS247550)in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma显示文摘	O'Connor OA Portlock C Moskowitz C	2008	Bri J Haematol2008，143，2：	1
12	Fracture resistance of anterior teeth restored with a novel nonmetallic post显示文摘	Abo EI-Ela OA Atta OA El-Mowafy O	2008	J Can Dent Assoc2008，74，5：	1
13	Targeting the proteasome pathway with bortezomib in patients with mantle cell(MCL)and follicular lymphoma(FL)produces prolonged progression free survival among responding patients:results ofa muhicenter phase Ⅱ experience显示文摘	O' Connor OA Wright J Moskowitz C	2005	Ann Oncol2005，16，5：	1
14	Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells显示文摘	WEI J DURAMAD O PERNG OA		0，，：	1
15	Histone deacetylase inhibitors: from target to clinical trials显示文摘	O'Connor OA Marks PA	2002	Expert Opin Investig Drugs2002，11，12：	1
16	Diffuse aggressive lymphoma显示文摘	Fisher RI Miller TP O'Connor OA	2004	Hematology Am Soc Hematol Educ Program2004，，：	1
17	Phase Ⅱ clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma显示文摘	O'Connor OA Wright J Moskowitz C	2005	J Clin Oncol2005，23，：	1
18	Metabolic biomarkers related to energy metabolism in Saudi autistic children 显示文摘	A1-Mosalem OA E1-Ansary A Attas O	2009	Clin Biochem2009，42，1011：	1
19	Phase I study of an oral histone deacetylase inhibitor,suberoylanilide hydroxamic acid,in patients with advanced cancer显示文摘	Kelly WK O'Connor OA Krug LM	2005	J Clin Oncol2005，23，17：	1
20	Behavioral effects of glutamate receptor agonists in morphine-dependent rats显示文摘	Dravolina OA Medve I O Bespalov AY	1999	Behav Pharmal1999，10，4：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示